Healthcare Public Relations
Biotech PR for Science That Is Not Finished Yet
Communications for biotech and life sciences companies — building a credible public narrative around science that is still in progress, without overpromising the outcome.
Why Choose AMW for Biotech PR
Biotech communications have a structural tension: the most interesting thing about your company may be years from proving out. You need investors, partners, and talent to believe in the science now, while being scrupulously accurate about what has and has not been demonstrated. Overstate it and you lose the scientific audience permanently. Understate it and you struggle to raise.
We work with biotech and life sciences companies to hold that line — building narratives that convey genuine scientific promise while being precise about stage, evidence, and uncertainty. In practice that means leading with mechanism and rationale rather than implied outcomes, and being explicit about what a given milestone does and does not establish.
From seed and Series A visibility through trial milestones, publications, partnerships, and platform expansion, we scope the programme to your stage. Biotech PR sits inside our wider healthcare PR practice and connects closely to our investor relations work.
Challenges
- Communicating scientific promise honestly when the outcome is genuinely not yet known
- Reaching investor and partner audiences without alienating scientific peers
- Explaining a novel mechanism or platform to journalists without a science background
- Building visibility during long, quiet development periods between readouts
- Competing for attention against companies willing to overstate their position
- Coordinating communications around publications, trial milestones, and financing events
Our Solutions
- Stage-accurate narratives that convey promise without implying results you do not have
- Mechanism-led storytelling that scientific audiences respect and generalists can follow
- Targeted outreach across life sciences trade, business, and investor-facing media
- Founder and chief scientific officer positioning as credible voices on the science
- Milestone communications planned around readouts, publications, and financing
- Sustained visibility programs for the long quiet stretches between events
Biotech PR Services
Specialized public relations solutions tailored for your industry
Life Sciences PR
Communications across the life sciences sector — therapeutics, platforms, research tools, and the companies commercializing them.
Trial Milestone Communications
Announcing study starts, enrollment milestones, and data readouts with precision about what each result establishes.
Funding and Partnership News
Financing rounds and pharma partnerships announced in a way that builds durable credibility, not just a single day of coverage.
Scientific Founder Positioning
Establishing your founder or chief scientific officer as a recognized voice on the mechanism, platform, or disease area.
Publication Support Communications
Coordinating public communications around peer-reviewed publications and conference presentations.
Investor-Facing Communications
Corporate narrative and visibility work that supports the investor conversation alongside the scientific one.
Ready to make a move on your biotech pr?
Get a tailored plan and pricing — no obligation, just a clear next step.
Why Work With AMW
Our Process
A proven approach to delivering exceptional biotech pr results
Science and Stage Assessment
We work through your platform, pipeline, and evidence to establish what can be claimed at your current stage and where the language must stay careful.
Narrative Development
We build the mechanism-led story that works for scientific peers, investors, and business press, with clear boundaries around what each milestone demonstrates.
Milestone-Aligned Outreach
Media and commentary programs sequenced around publications, trial milestones, partnerships, and financing events.
Reporting and Adjustment
Monthly reporting on coverage, message accuracy, and audience reception, with the narrative refined as the science progresses.
Science and Stage Assessment
We work through your platform, pipeline, and evidence to establish what can be claimed at your current stage and where the language must stay careful.
Narrative Development
We build the mechanism-led story that works for scientific peers, investors, and business press, with clear boundaries around what each milestone demonstrates.
Milestone-Aligned Outreach
Media and commentary programs sequenced around publications, trial milestones, partnerships, and financing events.
Reporting and Adjustment
Monthly reporting on coverage, message accuracy, and audience reception, with the narrative refined as the science progresses.
Who We Work With
Our biotech pr expertise serves a wide range of clients
"I love working with AMW, they are extremely professional & immensely helpful in helping to spread your work throughout the digital landscape we all are in today. Christine has been a huge help to me & I hope if you read this review that you get to work with her team !Looking forward to even more growth & great work from them !"
Related Tools & Resources
Related Content
Case Studies
Latest Insights
Frequently Asked Questions
What does a biotech PR agency do?
When should a biotech company start PR?
How do you communicate promise without overstating results?
How much does biotech PR cost?
Can you support us around a publication or conference?
What do we do during long quiet development periods?
More Public Relations specialties
Public Relations by city
Ready to Elevate Your Biotech PR?
Let's discuss how our specialized biotech pr expertise can drive results for your brand. Tailored strategy for your goals.